EBV positive primary cutaneous CD30+ large T-Cell lymphoma in a heart transplanted patient: Case report

American Journal of Transplantation

Volumn 4, Issue 11, 2004, Pages 1915-1920

  Lucioni, Marco ^a   Ippoliti, Giovanbattista ^b   Campana, Carlo ^c   Cavallini, Dario ^c   Incardona, Paolo ^a   Viglio, Alessandra ^a   Riboni, Roberta ^a   Viganò, Mario ^a   Magrini, Umberto ^a   Paulli, Marco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Hosp of Voghera Azienda Ospedaliera   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

CD30+ lymphoma; Post transplant lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; ENTEROCOLITIS; EPSTEIN BARR VIRUS; HEART FAILURE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISCHEMIC HEART DISEASE; LYMPH NODE METASTASIS; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHUMAN; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; RARE DISEASE; SIDE EFFECT; TREATMENT OUTCOME; TUMOR CELL;

EID: 7244221743     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00586.x     Document Type: Article

References (20)

1. Knowles DM, Cesarman E, Chadburn A et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85: 552-565.
2. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Posttransplant lymphoproliferative disorders. In:Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001: 264-271.
3. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101-1103.
4. Leblond V, Dhedin N, Bruneel MFM et al. Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. J Clin Oncol 2001; 19: 772-778.
5. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000; 24: 375-385.
6. Costes-Martineau V, Delfour C, Obled S et al. Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review. J Clin Pathol 2002; 55: 868-871.
7. Lee LY, Harpaz N, Strauchen JA. Posttransplant CD30+ (Ki-1) anaplastic large cell lymphoma: a case report and review of the literature. Arch Pathol Lab Med 2003; 127: 349-351.
8. Seçkin D, Demirhan B, Güleç TO, Arikan Ü, Haberal M. Posttransplantation primary cutaneous CD30 (Ki-1)-positive large-cell lymphoma. J Am Acad Dermatol 2001; 45: S197-S199.
9. Coyne JD, Banerjee SS, Bromley M, Mills S, Diss TC, Harris M. Post-transplant T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology 2004; 44: 387-393.
10. Ippoliti G, Martinelli L, Lorenzutti F, Incardona S, Negri M, Balduzzi P. Posttransplant lymphoproliferative disease after heart transplantation on Sandimmune therapy: treatment with interferon alfa-2b and intravenous immunoglobulin. Transpl Proc 1994; 26:2660-2661.
11. Cantarovich M, Barkun JS, Foebes RD, Kosiuk JP, Tchervenkov JI. Succesful treatment of post-transplant lymphoproliferative disorder with interferon-alfa and intravenous immunoglobulin. Clin Transpl 1998; 12: 109-115.
12. Stein H, Foss HD, Durkop H et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000; 96: 3681-3695.
13. Wood GS, Hardman DL, Boni R et al. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood 1996; 88: 1765-1770.
14. Paulli M, Berti E, Rosso Ret al. CD30/Ki-1-positive lymphoproliferative disorders of the skin-clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of cancer cutaneous lymphoma project group. J Clin Oncol 1995; 13: 1343-1354.
15. Bekkenk MW, Geelen FAMJ, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653-3661.
16. Van Gorp J, Doornewaard H, Verdonck LF, Klöpping C, Vos PF, van den Tweel JG. Posttransplant T-cell lymphoma. Report of three cases and review of the literature. Cancer 1994; 73: 3064-3072.
17. Kumar S, Kumar D, Kingma DW, Jaffe ES. Epstein-Barr Virus associated T-cell lymphoma in a renal transplant recipient. Am J Surg Pathol 1993; 17: 1046-1053.
18. Pitman SD, Rowsell EH, Cao JD, Huang Q, Wang J. Anaplastic large cell lymphoma associated with Epstein-Barr Virus following cardiac transplant. Am J Surg Pathol 2004; 28: 410-415.
19. Middeldorp JM, Brink AATP, van den Brule AJC, Meijer CJLM. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Critical Reviews in Oncology/Hematology 2003; 45: 1-36.
20. Hanson MN, Morrison VA, Peterson BA et al. Posttransplant T-cell lymphoproliferative disorders: an aggressive, late complication of solid-organ transplantation. Blood 1996; 88: 3626-3633.